These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8531667)

  • 1. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein.
    Hillyer GV
    Mem Inst Oswaldo Cruz; 1995; 90(2):249-53. PubMed ID: 8531666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
    Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
    Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
    Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
    Tendler M; Simpson AJ
    Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis.
    Vilar MM; Barrientos F; Almeida M; Thaumaturgo N; Simpson A; Garratt R; Tendler M
    Vaccine; 2003 Dec; 22(1):137-44. PubMed ID: 14604581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola antigens as vaccines against fascioliasis and schistosomiasis.
    Hillyer GV
    J Helminthol; 2005 Sep; 79(3):241-7. PubMed ID: 16153318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 Kd Fasciola hepatica cross-reactive antigen.
    Hillyer GV; García Rosa MI; Alicea H; Hernandez A
    Am J Trop Med Hyg; 1988 Jan; 38(1):103-10. PubMed ID: 3124643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of mice against schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica.
    Abáné JL; Oleaga A; Ramajo V; Casanueva P; Arellano JL; Hillyer GV; Muro A
    Vet Parasitol; 2000 Jul; 91(1-2):33-42. PubMed ID: 10889358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins.
    Muro A; Ramajo V; López J; Simón F; Hillyer GV
    Vet Parasitol; 1997 May; 69(3-4):219-29. PubMed ID: 9195732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract.
    Thaumaturgo N; Vilar MM; Diogo CM; Edelenyi R; Tendler M
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():79-83. PubMed ID: 11586430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen.
    Hillyer GV
    Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.
    Abán JL; Ramajo V; Arellano JL; Oleaga A; Hillyer GV; Muro A
    Vet Parasitol; 1999 Jun; 83(2):107-21. PubMed ID: 10392967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
    Hillyer GV; Soler de Galanes M; Battisti G
    Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
    Hillyer GV; Serrano AE
    Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.